Cryopyrin Associated Periodic Syndrome
8 clinical trials · Condition
◉ Watch Cryopyrin Associated Periodic Syndrome
| Record | Firm | Date |
|---|---|---|
| A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated Periodic Syndromes (CAPS) (NCT05186051) | Zydus Lifesciences Limited | 2022-06-01 |
| Adult Outcomes of Children With CAPS (NCT04856540) | University Hospital, Lille | 2021-09-16 |
| Study of ATI-450 in Patients With Cryopyrin-Associated Periodic Syndrome (CAPS) (NCT04524858) | Aclaris Therapeutics, Inc. | 2020-10-23 |
| Safety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334 (NCT04086602) | Inflazome UK Ltd | 2019-09-13 |
| The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in Canada (NCT01105507) | Novartis Pharmaceuticals | 2010-08-01 |
Track Cryopyrin Associated Periodic Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.